SLXN

Conviction 53HealthcareScan · Thu, Jun 25, 2026

Bullish belt hold

SLXN$2.68-0.74%

ResistanceSupportVol 14

Vol MA14 237.1K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Silexion Therapeutics CorpBiological Products, (No Diagnostic Substances)silexion.com ↗

Price2.68

Change-0.74%

Gap-2.41%

Rel volume0.07×

Avg volume267.35K

Avg $ vol718.72K

SMA 203.51

SMA 501.79

SMA 2002.30

Price vs 50+49.98%

Price vs 200+16.44%

MA stackmixed

50/200 cross—

Supertrenddown · 3.99

RSI (14)50

MACD hist-0.20

MACD crossbear · 8d

Stoch %K / %D13 / 13

ADX (14)26

+DI / −DI27 / 27

RSI divergence—

MACD divergence—

ATR %+16.54%

ADR %13.78%

52w high14.94

52w low0.2690

From 52w high-82.06%

Above 52w low+896.28%

New 52w highNo

SqueezeOff

Bollinger width137.58%

%B0.33

Donchian pos45.12%

Donchian high5.45

Donchian low0.4027

AVWAP (52w high)0.9998

vs AVWAP high+168.05%

AVWAP (52w low)0.5474

vs AVWAP low+389.62%

OBV trendFlat

Chaikin MF (20)0.19

Today vs 20d0.07×

Avg vol (14d)237.1K

Avg vol (20d)267.35K

Avg $ vol (20d)718.72K

Market cap11.23M

RS 3m (vs SPY)+89.24%

RS 6m (vs SPY)+4.76%

RS line new highNo

Trend template4/8

Technical rank79.2

1 week-7.59%

1 month+524.27%

3 months+88.73%

6 months+7.63%

1 year+226.83%

YTD+42.55%

P/E-0.94

P/B38.59

P/S—

P/FCF-1.04

EPS8.96

Div yield—

ROE—

ROA-258.84%

Debt/Eq—

Current1.00

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth27.89%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value8.82M

Revenue—

Net income-2.73M

Gross profit—

Free cash flow-10.83M

IndustryBiological Products, (No Diagnostic Substances)

ExchangeNasdaq

Shares out—

Employees13

ListedFri, Aug 16, 2024

Free float2.24M

Float %67.3%

Short interest154.97K

Days to cover0.0d

Short volume56.0%

Squeeze score25 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$8.50

Last surprise—

Setup gradeC

Conviction53 / 100

Pattern quality—

Tech rank79.2 / 100

Group rank—

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish belt hold

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SLXN

All disclosures →

No recent disclosed trades by Congress in SLXN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SLXN · 3 buys

Insider	Side	Shares	Value	Traded	Filed
Horenshtein Hadar Mirit CFO and Secretary · Ordinary Shares · 2026-06-04	Grant	7.5K	$0	2026-06-04	2026-06-08
Hadar Ilan Chairman and CEO · Ordinary Shares · 2026-06-04	Grant	10K	$0	2026-06-04	2026-06-08
Shirvan Mitchell CSO and CDO · Ordinary Shares · 2026-06-04	Grant	6K	$0	2026-06-04	2026-06-08
Hadar Ilan Chairman and CEO · Stock Option (right to buy Ordinary Shares) · 2026-06-04	Other	—	—	2026-06-04	2026-06-08
Shirvan Mitchell CSO and CDO · Stock Option (right to buy Ordinary Shares) · 2026-06-04	Other	—	—	2026-06-04	2026-06-08

SEC filings

EDGAR filings in SLXN · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.